Targeted drug delivery means sending medicine directly to the needed body part, lowering doses and avoiding harm elsewhere. This approach can help in immunotherapy, where the immune system fights diseases like cancer only at specific sites. The challenge is creating therapies that travel through the body and choose targets on their own.
Researchers at the University of Washington have developed proteins with autonomous decision-making capabilities. By appending smart tail structures to proteins, the team was able to create complex logic circuits, allowing the proteins to act based on the presence of biomarkers and specific environmental cues. The tails fold into shapes that use Boolean logic, with rules such as "and" or "or". For example, a protein might release its medicine only if both a certain enzyme and pH level are present, making delivery more accurate.
In tests, these proteins attached to carrier materials like hydrogels, small beads, or living cells. The proteins responded to up to five biomarkers, releasing cargo only when the right combination appeared. One carrier even held three different proteins, each programmed for unique cues.
Improving production with synthetic biology
Synthetic biology, which involves engineering living cells to build custom proteins, allowed quick and cheap manufacturing. Researchers designed DNA blueprints, inserted them into bacteria, and harvested the proteins in days instead of months. This scaled up production and added complexity to the logic circuits.
The method builds on earlier work where materials responded to single cues, but now handles combinations for better precision. It avoided manual building through old chemistry methods.
Potential uses include cancer therapies that hone in on tumors, or diagnostics like blood tests that change color for specific cue sets. Future work aims to find more biomarkers and collaborate on real treatments. The goal is materials that target any body spot, even single cells, for highly precise medicine. This advance brings smarter, scalable therapies closer to reality.
The researchers have detailed the methods and results of this study in a paper published in Nature Chemical Biology.